Legend Biotech Quick Ratio 2019-2022 | LEGN
Historical quick ratio values for Legend Biotech (LEGN) over the last 10 years.
| Legend Biotech Quick Ratio Historical Data |
| Date |
Current Assets - Inventory |
Current Liabilities |
Quick Ratio |
| 2022-03-31 |
$0.86B |
$0.23B |
3.81 |
| 2021-12-31 |
$0.95B |
$0.28B |
3.38 |
| 2021-09-30 |
$0.65B |
$0.28B |
2.37 |
| 2021-06-30 |
$0.72B |
$0.26B |
2.75 |
| 2021-03-31 |
$0.47B |
$0.15B |
3.24 |
| 2020-12-31 |
$0.59B |
$0.16B |
3.67 |
| 2020-09-30 |
$0.60B |
$0.12B |
4.87 |
| 2020-06-30 |
$0.67B |
$0.12B |
5.84 |
| 2020-03-31 |
$0.27B |
$0.11B |
2.40 |
| 2019-12-31 |
$0.21B |
$0.13B |
1.61 |
| 2019-09-30 |
$0.00B |
|
0.00 |
| 2019-06-30 |
$0.00B |
|
0.00 |
| 2019-03-31 |
$0.00B |
|
0.00 |
| 2018-12-31 |
$0.33B |
$0.16B |
2.05 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$8.483B |
$0.090B |
|
Legend Biotech Corporation is a clinical-stage biopharmaceutical company. It engaged in the discovery and development of novel cell therapies for oncology and other indications. The company's lead product consist LCAR-B38M/JNJ-4528, which are in clinical stage. Legend Biotech Corporation is based in Cayman Islands.
|
